TY - JOUR
T1 - Mucolytics for children with chronic suppurative lung disease
AU - McElrea, Esther
AU - Chang, Anne B.
AU - Yerkovich, Stephanie
AU - O'Farrell, Hannah E.
AU - Marchant, Julie M.
N1 - Funding Information:
EM: none known AC: received (via her institution) a grant from the European Respiratory Society SY: none known HO: none known JM: received a grant fellowship in bronchiectasis research from the Australian Lung Foundation.
Funding Information:
This project was supported by the National Institute for Health and Care Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Airways Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health and Social Care.
Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2022/7/25
Y1 - 2022/7/25
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of mucolytics for reducing exacerbations and improving quality of life in children with CSLD (including PBB and bronchiectasis), and to assess the risk of harm due to adverse events.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of mucolytics for reducing exacerbations and improving quality of life in children with CSLD (including PBB and bronchiectasis), and to assess the risk of harm due to adverse events.
UR - http://www.scopus.com/inward/record.url?scp=85134917711&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD015313
DO - 10.1002/14651858.CD015313
M3 - Article
AN - SCOPUS:85134917711
VL - 2022
SP - 1
EP - 13
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
SN - 1361-6137
IS - 7
M1 - CD015313
ER -